Please assess the completion status of the following clinical trial:

Trial Title: Forced Fluid Removal in High Risk Acute Kidney Injury

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 18 years of age~* Acute Kidney Injury defined according to the KDIGO criteria~* Renal Recovery Score ≤ 60%. (Calculated using www.renal-recovery-score.com)~* Fluid overload defined as a positive fluid balance ≥ 10% of ideal body weight.~* Able to undergo randomization within 12 hours of fulfilling other inclusion criteria~Exclusion Criteria:~* Known pre-hospitalization advanced chronic kidney disease. (eGFR \< 30 mL/minute/1.73 m2 or chronic RRT.)~* Severe hypoxic respiratory failure (use of invasive ventilation and FiO2 \> 80% and PEEP \> 10 cm H2O)~* Severe burn injury (≥ 10% TBSA)~* Severe hypo- or hyper- natremia (\< 120 or \> 155 mmol/l)~* Hepatic coma~* Mentally disabled undergoing forced treatment~* Pregnancy/breast feeding~* Lack of commitment for on-going life support including RRT~* Lack of informed consent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Forced Fluid Removal (Type: EXPERIMENTAL): The experimental intervention is guided by a therapeutic goal of average negative fluid balance ≥ 1 ml/kg/h and safety variables indicating inadequate circulation (lactate ≥ 4, MAP \< 50 or mottling beyond the edge of kneecaps).~The effect of fluid removal is evaluated three times daily (06:00. 14:00 and 22:00), while the safety variables are evaluated continuously. Resuscitation is started if one or more signs of inadequate circulation is present.~The first choice for fluid removal is diuretic therapy with furosemide, which is continued for a minimum of 8 hours. If the therapeutic goal (negative fluid balance ≥ 1 ml/kg/h) is not achieved and/or maintained by furosemide alone, then fluid removal with continuous renal replacement therapy (CRRT) is initiated.
- Usual Care (Type: ACTIVE_COMPARATOR): Usual Care at the discretion of the treating clinicians, except for the initiation of renal replacement therapy (RRT).

Based on this trial design, predict the completion outcome and termination type (if applicable).